A one
associates is a young regulatory
affairs consulting firm based in
Canada, and helping small, medium
healthcare enterprises to access the
middle east market.
The regulatory landscape of each country is dynamically evolving with new medical regulations and requirements of local health authorities which create the need for dedicated regulatory professionals or organizations to ease the flow and growth of the business. The increased focus in emerging markets and rapid changes in the local regulations to meet the global standards is stipulating the need for strategic regulatory management. A one offer a differentiated service with regulatory intelligence, expertise and experience combined with insights for a faster access to EMEA. We act as a single point contact for all your regulatory needs in the region. We have our network of offices and affiliates across the region to provide quality and consistent service.
Vision : To be the preferred partner of regulatory affairs management for healthcare companies in Middle East region.
Mission : We aim to be recognized as a preferred choice of regulatory management partner for small and medium healthcare companies across the globe to expand in the Middle East.
Our Products
Services
Product Registration
A one helps in accessing the Middle East market in a most efficient manner, with local offices and partners across the region. Our team with expert know- how and excellent relationship with health and other relevant authorities offers an exemplary services to register the products in a time bound manner to launch and build the brands in the region.
In country representation
A one act as your legal representative in the region through our affiliates and service partners. We offer all services for pre marketing and post marketing phases in a fast, affordable and most effective way.
Distributor qualification
A one associates helps it partners to identify, analyze, choose and manage distributors in the region. The regional know-how and extensive experience allows our experts to prequalify distributors based on their capabilities, geographical reach and reputation to ease the process for our partners.
Regulatory consulting and intelligence
Our Regulatory and strategic intelligence team comprises experts with extensive experiences in regional registration. The team manages the regional regulatory strategies in alignment with global strategies of the partners to enable the optimal registration strategies to achieve the regulatory goals.
News
UAE sets out plan to become major global pharma hub
Country aims to double number of drugs manufacturing factories by 2021, attract more pharma firms.The UAE Ministry of Health and Prevention and Jafza, a DP World company, have signed a memorandum of understanding for the development of the healthcare and pharmaceutical sector in the country. Under the agreement, the UAE aims to attract more than 75 major pharmaceutical firms by 2021 up from the current 54 today, with investments of up to AED2 billion annually. The number of drugs manufacturing factories is expected to grow from 17 to 34 in the same period. The agreement is part of Jafza’s efforts to enhance the healthcare sector by providing the environment for companies to grow and establish Made in Dubai pharmaceutical products, a statement said. It added that Jafza will develop details for the licensing of pharmaceutical factories within the Free Zone and help them promote public health.